Cover Image

Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers

A new series of pyrido[2,3-d]pyrimidin-4(3H)-one derivatives having the essential pharmacophoric features of EGFR inhibitors has been designed and synthesised. Cell viability screening was performed for these compounds against A-549, PC-3, HCT-116, and MCF-7 cell lines at a dose of 100 μM. The highe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Heba S. A. Elzahabi (Author), Eman S. Nossier (Author), Rania A. Alasfoury (Author), May El-Manawaty (Author), Sara M. Sayed (Author), Eslam B. Elkaeed (Author), Ahmed M. Metwaly (Author), Mohamed Hagras (Author), Ibrahim H. Eissa (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790M
by: Ahmed A. Gaber, et al.
Published: (2022)

Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold
by: Heba S. A. Elzahabi, et al.
Published: (2018)

Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFRWT and EGFRT790M inhibitors
by: Tarfah Al-Warhi, et al.
Published: (2023)

Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFRWT/EGFRT790M inhibitors
by: Lamya H. Al-Wahaibi, et al.
Published: (2023)

Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFRWT, EGFRT790M, and EGFRL858R)
by: Mahmoud G. Abo Al-Hamd, et al.
Published: (2023)

Design, synthesis, and molecular docking studies of novel pomalidomide-based PROTACs as potential anti-cancer agents targeting EGFRWT and EGFRT790M
by: Moustafa O. Aboelez, et al.
Published: (2022)

Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFRL858R/T790M inhibitors
by: Jianfang Fu, et al.
Published: (2023)

Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors
by: Eman A. Sobh, et al.
Published: (2023)

Synthesis and cytotoxic evaluation of some novel 3-[2-(2-phenyl-thiazol-4-yl)-ethyl] -3H-pyrido [2,3-d]pyrimidin-4-one derivatives
by: Marzieh Rahmani Khajouei, et al.
Published: (2021)

Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity
by: Asmaa A. Mandour, et al.
Published: (2022)

Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation
by: Mohamed Hagras, et al.
Published: (2021)

Microwave-Assisted Synthesis of Potential Bioactive Benzo-, Pyrido- or Pyrazino-thieno[3,2-<i>d</i>]pyrimidin-4-amine Analogs of MPC-6827
by: Yvonnick Loidreau, et al.
Published: (2020)

Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-<i>d</i>], [3,2-<i>d</i>], [3,4-<i>d</i>] and [4,3-<i>d</i>]pyrimidine Derivatives
by: Joana F. Campos, et al.
Published: (2022)

Expanding the Diversity at the C-4 Position of Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones to Achieve Biological Activity against ZAP-70
by: Victor Masip, et al.
Published: (2021)

Identification of Novel Cyanopyridones and Pyrido[2,3-<em>d</em>]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies
by: Tarfah Al-Warhi, et al.
Published: (2022)

Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
by: Nasser S.M. Ismail, et al.
Published: (2016)

Anticancer Activity Evaluation of New Thieno[2,3-d]pyrimidin-4(3H)-ones and Thieno[3,2-d]pyrimidin-4(3H)-one Derivatives
by: Olga Shyyka, et al.
Published: (2018)

SYNTHESIS AND ANTIMICROBIAL EVALUATION OF 2-[(SUBSTITUEDPHENYL)-5-(1-PHENYL-3-(PIPERAZINYL)PYRIDO[3,2-f]QUINAZOLIN-4(1H)-YL]-1,3,4-THIADIAZOLES
by: Ranjana Dubey, et al.
Published: (2016)

New derivatives of hydrogenated pyrido[4,3-b]indoles as potential neuroprotectors: Synthesis, biological testing and solubility in pharmaceutically relevant solvents
by: Svetlana Blokhina, et al.
Published: (2018)

Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
by: Eman Z. Elrazaz, et al.
Published: (2015)

Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach
by: Muhammad Tukur Ibrahim, et al.
Published: (2021)

N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway
by: Chakrabhavi Dhananjaya Mohan, et al.
Published: (2018)

1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies
by: Mohamed Hagras, et al.
Published: (2022)

Design, synthesis, docking, and anticancer evaluations of new thiazolo[3,2-a] pyrimidines as topoisomerase II inhibitors
by: Mona S. El-Zoghbi, et al.
Published: (2023)

Pyrido[2',1':2,3]imidazo[4,5-<i>c</i>]isoquinolin-5-amines as Potential Cytotoxic Agents against Human Neuroblastoma
by: Zahira Tber, et al.
Published: (2021)

N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output
by: Igor V. Ukrainets, et al.
Published: (2018)

Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
by: Marwa A. Aziz, et al.
Published: (2016)

3D-QSAR and Docking Studies on Pyrimidine Derivatives of Second-Generation ALK Inhibitors
by: Gang-Long Jiang, et al.
Published: (2022)

Nucleoside cyclic 3',5'-phosphorothioates with purine and pyrimidine scaffolds. A chemical minireview
by: Kjell Undheim
Published: (2022)

Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFR<sup>L858R/T790M</sup> Mutations
by: Moamen A. Hassanin, et al.
Published: (2022)

New Quinazolin-4(3<i>H</i>)-one Derivatives Incorporating Hydrazone and Pyrazole Scaffolds as Antimicrobial Agents Targeting DNA Gyraze Enzyme
by: Eman M. Mohi El-Deen, et al.
Published: (2022)

Novel 4-arylaminoquinazolines bearing N,N-diethyl(aminoethyl)amino moiety with antitumour activity as EGFRwt-TK inhibitor
by: Yaling Zhang, et al.
Published: (2019)

EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
by: Minhye Kim, et al.
Published: (2021)

Design and synthesis of some substituted thiazolo[3,2-a]pyrimidine derivatives of potential biological activities
by: Samia G. Abdel Moty, et al.
Published: (2016)

4-Substituted Thieno[3,2-<i>d</i>]pyrimidines as Dual-Stage Antiplasmodial Derivatives
by: Prisca Lagardère, et al.
Published: (2022)

The Role of Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitors in The Attenuation of CCl<sub>4</sub>-Induced Liver Fibrosis in Rats
by: Diana K. Ghobrial, et al.
Published: (2023)

Design and synthesis of novel pyrazolo[4,3-d]pyrimidines as potential therapeutic agents for acute lung injury
by: Bao Shi Wang, et al.
Published: (2019)

Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study
by: Fatma M. Elmenier, et al.
Published: (2022)

Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
by: Ashwag S. Alanazi, et al.
Published: (2023)

Synthesis and biological activity of 2-[6-methyl-4-(thietan-3-yloxy)pyrimidin-2-ylthio]acetohydrazide derivatives
by: Svetlana Meshcheryakova, et al.
Published: (2021)